Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C McKaig

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|March 16, 2001
Current pharmacotherapy for inflammatory bowel diseaseB C McKaig, W A Stack
Expert Opinion on Investigational Drugs|July 5, 2005
Novel approaches to inflammatory bowel diseaseB C McKaig, W A Stack
American Journal of Physiology. Cell Physiology|December 18, 2001
Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblastsB C McKaig, K Hughes, P J Tighe, et al.
Frontline Gastroenterology|August 26, 2017
Development and roll out of the JETS e-portfolio: a web based electronic portfolio for endoscopistsT Mehta, K Dowler, B C McKaig, et al.
The American Journal of Physiology|May 18, 1999
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3B C McKaig, S S Makh, C J Hawkey, et al.
The American Journal of Physiology|August 13, 1999
Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory responseJ Beltinger, B C McKaig, S Makh, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 22, 2009
Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centreP Ellul, E Fogden, C L Simpson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|March 16, 2001
Current pharmacotherapy for inflammatory bowel diseaseB C McKaig, W A Stack
Expert Opinion on Investigational Drugs|July 5, 2005
Novel approaches to inflammatory bowel diseaseB C McKaig, W A Stack
American Journal of Physiology. Cell Physiology|December 18, 2001
Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblastsB C McKaig, K Hughes, P J Tighe, et al.
Frontline Gastroenterology|August 26, 2017
Development and roll out of the JETS e-portfolio: a web based electronic portfolio for endoscopistsT Mehta, K Dowler, B C McKaig, et al.
The American Journal of Physiology|May 18, 1999
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3B C McKaig, S S Makh, C J Hawkey, et al.
The American Journal of Physiology|August 13, 1999
Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory responseJ Beltinger, B C McKaig, S Makh, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 22, 2009
Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centreP Ellul, E Fogden, C L Simpson, et al.
Pageof 1